Global Blood-Brain Barrier Transport Drugs Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Blood-Brain Barrier Transport Drugs Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2035184
  • Published Date :
    May 1, 2022
  • Number of Pages :
    300.0

Product Description

The blood–brain barrier (BBB) prevents the brain uptake of most pharmaceuticals. This property arises from the epithelial-like tight junctions within the brain capillary endothelium. The BBB is anatomically and functionally distinct from the blood–cerebrospinal fluid barrier at the choroid plexus. Certain small molecule drugs may cross the BBB via lipid-mediated free diffusion, providing the drug has a molecular weight <400?Da and forms <8 hydrogen bonds. These chemical properties are lacking in the majority of small molecule drugs, and all large molecule drugs. Nevertheless, drugs can be reengineered for BBB transport, based on the knowledge of the endogenous transport systems within the BBB. Small molecule drugs can be synthesized that access carrier-mediated transport (CMT) systems within the BBB. Large molecule drugs can be reengineered with molecular Trojan horse delivery systems to access receptor-mediated transport (RMT) systems within the BBB.
The Blood-Brain Barrier Transport Drugs market revenue was xx Million USD in 2018, grew to xx Million USD in 2021, and will reach xx Million USD in 2030, with a CAGR of xx during 2022-2030.

Considering the influence of COVID-19 on the global Blood-Brain Barrier Transport Drugs market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Blood-Brain Barrier Transport Drugs Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Blood-Brain Barrier Transport Drugs market are:
Dainippon Sumitomo Pharma
Bioasis
Fluorinov Pharma
Palobiofarma
Immune Pharmaceuticals
Fondazione Telethon
AZ Therapies
Minoryx
CarThera
BioAdvance
Cyclenium
BrainsGate
EIP Pharma
Bach Pharma
NewGen Therapeutics

Most important types of Blood-Brain Barrier Transport Drugs products covered in this report are:
Carrier-mediated Transport
Receptor-mediated Transport
Absorptive-mediated Transport
Active Efflux Transport
Others

Most widely used downstream fields of Blood-Brain Barrier Transport Drugs market covered in this report are:
Alzheimer's Disease
Epilepsy
Parkinson's Disease
Multiple Sclerosis
Hunter's Syndrome
Brain Cancer
Others

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.





Table of Content

Table of Content

1 Blood-Brain Barrier Transport Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Blood-Brain Barrier Transport Drugs
1.3 Blood-Brain Barrier Transport Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Blood-Brain Barrier Transport Drugs
1.4.2 Applications of Blood-Brain Barrier Transport Drugs
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Blood-Brain Barrier Transport Drugs Industry Trends
1.5.2 Blood-Brain Barrier Transport Drugs Drivers
1.5.3 Blood-Brain Barrier Transport Drugs Market Challenges
1.5.4 Blood-Brain Barrier Transport Drugs Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Blood-Brain Barrier Transport Drugs Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Blood-Brain Barrier Transport Drugs Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Blood-Brain Barrier Transport Drugs Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Blood-Brain Barrier Transport Drugs
2.2.1 Major Players Manufacturing Base of Blood-Brain Barrier Transport Drugs in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Blood-Brain Barrier Transport Drugs Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Blood-Brain Barrier Transport Drugs
2.3.3 Labor Cost of Blood-Brain Barrier Transport Drugs
2.4 Market Channel Analysis of Blood-Brain Barrier Transport Drugs
2.5 Major Down Stream Customers by Application

3 Global Blood-Brain Barrier Transport Drugs Market, by Type
3.1 Global Blood-Brain Barrier Transport Drugs Revenue and Market Share by Type (2018-2021)
3.2 Global Blood-Brain Barrier Transport Drugs Production and Market Share by Type (2018-2021)
3.3 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate of Carrier-mediated Transport
3.3.2 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate of Receptor-mediated Transport
3.3.3 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate of Absorptive-mediated Transport
3.3.4 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate of Active Efflux Transport
3.3.5 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate of Others
3.4 Global Blood-Brain Barrier Transport Drugs Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Blood-Brain Barrier Transport Drugs Market, by Application
4.1 Downstream Market Overview
4.2 Global Blood-Brain Barrier Transport Drugs Consumption and Market Share by Application (2018-2021)
4.3 Global Blood-Brain Barrier Transport Drugs Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Blood-Brain Barrier Transport Drugs Consumption and Growth Rate of Alzheimer's Disease (2018-2021)
4.3.2 Global Blood-Brain Barrier Transport Drugs Consumption and Growth Rate of Epilepsy (2018-2021)
4.3.3 Global Blood-Brain Barrier Transport Drugs Consumption and Growth Rate of Parkinson's Disease (2018-2021)
4.3.4 Global Blood-Brain Barrier Transport Drugs Consumption and Growth Rate of Multiple Sclerosis (2018-2021)
4.3.5 Global Blood-Brain Barrier Transport Drugs Consumption and Growth Rate of Hunter's Syndrome (2018-2021)
4.3.6 Global Blood-Brain Barrier Transport Drugs Consumption and Growth Rate of Brain Cancer (2018-2021)
4.3.7 Global Blood-Brain Barrier Transport Drugs Consumption and Growth Rate of Others (2018-2021)

5 Global Blood-Brain Barrier Transport Drugs Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Blood-Brain Barrier Transport Drugs Revenue and Market Share by Region (2018-2021)
5.2 Global Blood-Brain Barrier Transport Drugs Consumption and Market Share by Region (2018-2021)
5.3 Global Blood-Brain Barrier Transport Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Blood-Brain Barrier Transport Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Blood-Brain Barrier Transport Drugs Market Under COVID-19
5.4.2 North America Blood-Brain Barrier Transport Drugs SWOT Analysis
5.5 Europe Blood-Brain Barrier Transport Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Blood-Brain Barrier Transport Drugs Market Under COVID-19
5.5.2 Europe Blood-Brain Barrier Transport Drugs SWOT Analysis
5.6 China Blood-Brain Barrier Transport Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Blood-Brain Barrier Transport Drugs Market Under COVID-19
5.6.2 China Blood-Brain Barrier Transport Drugs SWOT Analysis
5.7 Japan Blood-Brain Barrier Transport Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Blood-Brain Barrier Transport Drugs Market Under COVID-19
5.7.2 Japan Blood-Brain Barrier Transport Drugs SWOT Analysis
5.8 Middle East and Africa Blood-Brain Barrier Transport Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Blood-Brain Barrier Transport Drugs Market Under COVID-19
5.8.2 Middle East and Africa Blood-Brain Barrier Transport Drugs SWOT Analysis
5.9 India Blood-Brain Barrier Transport Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Blood-Brain Barrier Transport Drugs Market Under COVID-19
5.9.2 India Blood-Brain Barrier Transport Drugs SWOT Analysis
5.10 South America Blood-Brain Barrier Transport Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Blood-Brain Barrier Transport Drugs Market Under COVID-19
5.10.2 South America Blood-Brain Barrier Transport Drugs SWOT Analysis
5.11 South Korea Blood-Brain Barrier Transport Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Blood-Brain Barrier Transport Drugs Market Under COVID-19
5.11.2 South Korea Blood-Brain Barrier Transport Drugs SWOT Analysis
5.12 Southeast Asia Blood-Brain Barrier Transport Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Blood-Brain Barrier Transport Drugs Market Under COVID-19
5.12.2 Southeast Asia Blood-Brain Barrier Transport Drugs SWOT Analysis

6 Global Blood-Brain Barrier Transport Drugs Production by Top Regions (2018-2021)
6.1 Global Blood-Brain Barrier Transport Drugs Production by Top Regions (2018-2021)
6.2 North America Blood-Brain Barrier Transport Drugs Production and Growth Rate
6.3 Europe Blood-Brain Barrier Transport Drugs Production and Growth Rate
6.4 China Blood-Brain Barrier Transport Drugs Production and Growth Rate
6.5 Japan Blood-Brain Barrier Transport Drugs Production and Growth Rate
6.6 India Blood-Brain Barrier Transport Drugs Production and Growth Rate

7 Global Blood-Brain Barrier Transport Drugs Consumption by Regions (2018-2021)
7.1 Global Blood-Brain Barrier Transport Drugs Consumption by Regions (2018-2021)
7.2 North America Blood-Brain Barrier Transport Drugs Consumption and Growth Rate
7.3 Europe Blood-Brain Barrier Transport Drugs Consumption and Growth Rate
7.4 China Blood-Brain Barrier Transport Drugs Consumption and Growth Rate
7.5 Japan Blood-Brain Barrier Transport Drugs Consumption and Growth Rate
7.6 Middle East & Africa Blood-Brain Barrier Transport Drugs Consumption and Growth Rate
7.7 India Blood-Brain Barrier Transport Drugs Consumption and Growth Rate
7.8 South America Blood-Brain Barrier Transport Drugs Consumption and Growth Rate
7.9 South Korea Blood-Brain Barrier Transport Drugs Consumption and Growth Rate
7.10 Southeast Asia Blood-Brain Barrier Transport Drugs Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Dainippon Sumitomo Pharma Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.2.3 Dainippon Sumitomo Pharma Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Bioasis Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.3.3 Bioasis Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Fluorinov Pharma Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.4.3 Fluorinov Pharma Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Palobiofarma Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.5.3 Palobiofarma Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Immune Pharmaceuticals Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.6.3 Immune Pharmaceuticals Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Fondazione Telethon Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.7.3 Fondazione Telethon Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 AZ Therapies Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.8.3 AZ Therapies Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Minoryx Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.9.3 Minoryx Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 CarThera Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.10.3 CarThera Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 BioAdvance Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.11.3 BioAdvance Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Cyclenium Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.12.3 Cyclenium Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 BrainsGate Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.13.3 BrainsGate Sales, Revenue, Price, Gross Margin 2018-2021
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 EIP Pharma Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.14.3 EIP Pharma Sales, Revenue, Price, Gross Margin 2018-2021
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Bach Pharma Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.15.3 Bach Pharma Sales, Revenue, Price, Gross Margin 2018-2021
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 NewGen Therapeutics Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Blood-Brain Barrier Transport Drugs Product Profiles, Application and Specification
8.16.3 NewGen Therapeutics Sales, Revenue, Price, Gross Margin 2018-2021
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Blood-Brain Barrier Transport Drugs Market Analysis and Forecast by Type and Application
9.1 Global Blood-Brain Barrier Transport Drugs Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Carrier-mediated Transport Market Revenue and Volume Forecast (2021-2026)
9.1.2 Receptor-mediated Transport Market Revenue and Volume Forecast (2021-2026)
9.1.3 Absorptive-mediated Transport Market Revenue and Volume Forecast (2021-2026)
9.1.4 Active Efflux Transport Market Revenue and Volume Forecast (2021-2026)
9.1.5 Others Market Revenue and Volume Forecast (2021-2026)
9.2 Global Blood-Brain Barrier Transport Drugs Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Alzheimer's Disease Market Revenue and Volume Forecast (2021-2026)
9.2.2 Epilepsy Market Revenue and Volume Forecast (2021-2026)
9.2.3 Parkinson's Disease Market Revenue and Volume Forecast (2021-2026)
9.2.4 Multiple Sclerosis Market Revenue and Volume Forecast (2021-2026)
9.2.5 Hunter's Syndrome Market Revenue and Volume Forecast (2021-2026)
9.2.6 Brain Cancer Market Revenue and Volume Forecast (2021-2026)
9.2.7 Others Market Revenue and Volume Forecast (2021-2026)

10 Blood-Brain Barrier Transport Drugs Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Blood-Brain Barrier Transport Drugs Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?

Search results for Biotechnology Industry